Skip to main content

Mesoridazine Pregnancy and Breastfeeding Warnings

Brand names: Serentil

Mesoridazine Pregnancy Warnings

Mesoridazine has not been formally assigned to a pregnancy category by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Mesoridazine is only recommended for use during pregnancy when the potential benefits outweigh potential risks.

See references

Mesoridazine Breastfeeding Warnings

There are no data on the excretion of mesoridazine into human milk. Because many drugs are excreted into human milk, and because of the potential for serious adverse reactions in nursing infants from mesoridazine, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

See also

References for pregnancy information

  1. Product Information. Serentil (mesoridazine). Boehringer-Ingelheim. 2001;PROD.

References for breastfeeding information

  1. Product Information. Serentil (mesoridazine). Boehringer-Ingelheim. 2001;PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer